Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme L
Recalled December 31, 2025 · FDA recall D-0241-2026 · Merck Sharp & Dohme
Hazard
Presence of particulate matter: potential presence of metal particulates in the product. · FDA Class II
Units
3 - single dose kits
Sold at
Nationwide in the USA
Description
Presence of particulate matter: potential presence of metal particulates in the product.
Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Manufacturer(s)
Merck Sharp & Dohme LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →